169 related articles for article (PubMed ID: 29197134)
1. Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics.
Severi E; Ferrara M; Tedeschini E; Vacca F; Mungai F; Amendolara R; Baccari F; Starace F
Int J Ment Health Nurs; 2018 Jun; 27(3):1002-1008. PubMed ID: 29197134
[TBL] [Abstract][Full Text] [Related]
2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics.
Devlin AM; Ngai YF; Ronsley R; Panagiotopoulos C
Transl Psychiatry; 2012 Jan; 2(1):e71. PubMed ID: 22832733
[TBL] [Abstract][Full Text] [Related]
4. Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment.
Sjo CP; Stenstrøm AD; Bojesen AB; Frølich JS; Bilenberg N
J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):884-891. PubMed ID: 28783382
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.
Seow LS; Chong SA; Wang P; Shafie S; Ong HL; Subramaniam M
Compr Psychiatry; 2017 Apr; 74():196-203. PubMed ID: 28214752
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
[TBL] [Abstract][Full Text] [Related]
8. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder.
Fiedorowicz JG; Palagummi NM; Forman-Hoffman VL; Miller DD; Haynes WG
Ann Clin Psychiatry; 2008; 20(3):131-7. PubMed ID: 18633739
[TBL] [Abstract][Full Text] [Related]
9. Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics.
Panagiotopoulos C; Ronsley R; Kuzeljevic B; Davidson J
Can J Psychiatry; 2012 Jan; 57(1):34-44. PubMed ID: 22296966
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome: differences between psychiatric and internal medicine patients.
Margari F; Lozupone M; Pisani R; Pastore A; Todarello O; Zagaria G; Minerva F; Palasciano G; Palmieri V
Int J Psychiatry Med; 2013; 45(3):203-26. PubMed ID: 24066405
[TBL] [Abstract][Full Text] [Related]
11. Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications.
Straker D; Correll CU; Kramer-Ginsberg E; Abdulhamid N; Koshy F; Rubens E; Saint-Vil R; Kane JM; Manu P
Am J Psychiatry; 2005 Jun; 162(6):1217-21. PubMed ID: 15930076
[TBL] [Abstract][Full Text] [Related]
12. N-3 fatty acids for hypertriglyceridemia in patients taking second-generation antipsychotics.
Fetter JC; Brunette M; Green AI
Clin Schizophr Relat Psychoses; 2013; 7(2):73-77A. PubMed ID: 23367502
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study.
Bobes J; Arango C; Aranda P; Carmena R; Garcia-Garcia M; Rejas J;
Eur Psychiatry; 2012 May; 27(4):267-74. PubMed ID: 21036549
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
Wysokiński A; Kowman M; Kłoszewska I
Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
[TBL] [Abstract][Full Text] [Related]
15. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.
Liu J; Joshi D; Sempos CT
Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043
[TBL] [Abstract][Full Text] [Related]
16. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
[TBL] [Abstract][Full Text] [Related]
17. Body mass, cardiovascular risk and metabolic characteristics of young persons presenting for mental healthcare in Sydney, Australia.
Scott EM; Hermens DF; White D; Naismith SL; GeHue J; Whitwell BG; Glozier N; Hickie IB
BMJ Open; 2015 Mar; 5(3):e007066. PubMed ID: 25818274
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Chart Review of Screening on the Prevalence of Metabolic Syndrome (MetS) in an Irish Community Mental Health Service.
Cocoman AM; Gallagher D
Issues Ment Health Nurs; 2019 Oct; 40(10):895-901. PubMed ID: 31295053
[TBL] [Abstract][Full Text] [Related]
19. A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study.
Arango C; Bobes J; Aranda P; Carmena R; Garcia-Garcia M; Rejas J;
Schizophr Res; 2008 Sep; 104(1-3):1-12. PubMed ID: 18606526
[TBL] [Abstract][Full Text] [Related]
20. Health behaviour beliefs and physical health risk factors for cardiovascular disease in an outpatient sample of consumers with a severe mental illness: a cross-sectional survey.
Brunero S; Lamont S
Int J Nurs Stud; 2010 Jun; 47(6):753-60. PubMed ID: 19959166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
